Published in J Neuropathol Exp Neurol on March 01, 1990
Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. Am J Hum Genet (1991) 1.30
Full-length dystrophin expression in half of the heart cells ameliorates beta-isoproterenol-induced cardiomyopathy in mdx mice. Hum Mol Genet (2004) 1.25
Low dystrophin levels increase survival and improve muscle pathology and function in dystrophin/utrophin double-knockout mice. FASEB J (2013) 1.11
Inhibition of myosatellite cell proliferation by gamma irradiation does not prevent the age-related increase of the number of dystrophin-positive fibers in soleus muscles of mdx female heterozygote mice. Am J Pathol (1991) 0.79
The change in dystrophin phenotype in heterozygous mdx mice. J Neuropathol Exp Neurol (1991) 0.78
Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy. Hum Genet (2016) 0.76
Catastrophic shifts in ecosystems. Nature (2001) 25.57
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell (1996) 5.99
AnkyrinG is required for clustering of voltage-gated Na channels at axon initial segments and for normal action potential firing. J Cell Biol (1998) 4.41
Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet (1997) 4.29
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13
The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature (1988) 3.85
Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature (1990) 3.84
Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature (1986) 3.62
A full genome search in multiple sclerosis. Nat Genet (1996) 2.96
Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82
The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced. Nat Genet (1995) 2.76
A comparison of the caffeine halothane muscle contracture test with the molecular genetic diagnosis of malignant hyperthermia. Anesthesiology (1991) 2.67
A population-based study of multiple sclerosis in twins. N Engl J Med (1986) 2.59
FGFR2 mutation associated with clinical manifestations consistent with Antley-Bixler syndrome. Am J Med Genet (1998) 2.56
A cDNA clone from the Duchenne/Becker muscular dystrophy gene. Nature (1987) 2.55
Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet (1998) 2.51
Proximal axonal enlargement in motor neuron disease. Neurology (1968) 2.48
Physical separation of hemopoietic stem cells from cells forming colonies in culture. J Cell Physiol (1969) 2.46
Nonsexual transmission of sexually transmitted diseases: an infrequent occurrence. Pediatrics (1984) 2.44
Dystrophin is localized to the plasma membrane of human skeletal muscle fibers by electron-microscopic cytochemical study. Muscle Nerve (1990) 2.41
Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet (1990) 2.20
Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia. Nature (1990) 2.20
Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group. Neurology (1991) 2.16
Prevalence of pre-cancerous lesions and cervical cancer in South Africa--a multicentre study. S Afr Med J (2002) 2.13
Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. N Engl J Med (1990) 1.98
Late-onset mitochondrial myopathy. Ann Neurol (1995) 1.98
Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol (1988) 1.94
A pilot study of the continuous glucose monitoring system: clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care (2001) 1.89
Assignment of the gene for complete X-linked congenital stationary night blindness (CSNB1) to Xp11.3. Genomics (1989) 1.87
Chromosome stability in CHO cells. Somatic Cell Genet (1977) 1.86
Duchenne muscular dystrophy involving translocation of the dmd gene next to ribosomal RNA genes. Science (1984) 1.85
Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet (1992) 1.81
Segregation of recessive phenotypes in somatic cell hybrids: role of mitotic recombination, gene inactivation, and chromosome nondisjunction. Mol Cell Biol (1981) 1.80
Polarized angular dependent spectroscopy of epithelial cells and epithelial cell nuclei to determine the size scale of scattering structures. J Biomed Opt (2002) 1.78
Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J Neurol Sci (1990) 1.78
A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics (1991) 1.77
Karyotyping. Methods Enzymol (1979) 1.75
Partial gene duplication as a cause of human disease. Hum Mutat (1992) 1.73
Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve (1988) 1.67
Development and initial evaluation of a real-time RT-PCR assay to detect bluetongue virus genome segment 1. J Virol Methods (2007) 1.66
Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology (1978) 1.65
Neurofibrillary axonal swellings and amyotrophic lateral sclerosis. J Neurol Sci (1984) 1.65
Expression of an X-linked muscular dystrophy in a female due to translocation involving Xp21 and non-random inactivation of the normal X chromosome. Hum Genet (1984) 1.64
Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol Cell Biol (1990) 1.64
Isolation of human cDNAs for asparagine synthetase and expression in Jensen rat sarcoma cells. Mol Cell Biol (1987) 1.61
Functional inactivation of bacteriophage lambda morphogenetic gene in RNA. Nature (1975) 1.60
Endoscopic ultrasound is highly accurate and directs management in patients with neuroendocrine tumors of the pancreas. Am J Gastroenterol (2000) 1.59
Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet (2001) 1.58
Clinical phenotypes of different MPZ (P0) mutations may include Charcot-Marie-Tooth type 1B, Dejerine-Sottas, and congenital hypomyelination. Neuron (1996) 1.58
Identification of the activation domain of equine infectious anemia virus rev. J Virol (1993) 1.57
'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy. Brain (1977) 1.56
Kufs' disease: a critical reappraisal. Brain (1988) 1.55
Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am J Pathol (1989) 1.55
Structural requirements for association of neurofascin with ankyrin. J Biol Chem (1998) 1.53
Molecular analysis of a constitutional X-autosome translocation in a female with muscular dystrophy. Science (1987) 1.53
Mechanisms of tandem duplication in the Duchenne muscular dystrophy gene include both homologous and nonhomologous intrachromosomal recombination. EMBO J (1991) 1.53
Clinical signs and pathology shown by British sheep and cattle infected with bluetongue virus serotype 8 derived from the 2006 outbreak in northern Europe. Vet Rec (2007) 1.52
Specific involvement of muscle, nerve, and skin in late infantile and juvenile amaurotic idiocy. Neurology (1972) 1.51
Partial gene duplication in Duchenne and Becker muscular dystrophies. J Med Genet (1988) 1.50
Linkage of genetic markers emt and chr in Chinese hamster cells. Somatic Cell Genet (1980) 1.49
Mapping of four translocation breakpoints within the Duchenne muscular dystrophy gene. Genomics (1989) 1.45
Duchenne muscular dystrophy: plasma membrane loss initiates muscle cell necrosis unless it is repaired. Brain (1979) 1.44
Identification of alternatively spliced mRNAs encoding potential new regulatory proteins in cattle infected with bovine leukemia virus. J Virol (1993) 1.42
Subacute necrotizing encephalomyelopathy. A review and a study of two families. Brain (1971) 1.42
Combined central and peripheral myelinopathy. Neurology (1987) 1.40
The human skeletal muscle Na channel mutation R669H associated with hypokalemic periodic paralysis enhances slow inactivation. J Neurosci (2000) 1.40
Multipoint linkage analysis and heterogeneity testing in 20 X-linked retinitis pigmentosa families. Genomics (1990) 1.38
Human ribosomal RNA genes: orientation of the tandem array and conservation of the 5' end. Science (1988) 1.38
The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology (1975) 1.38
Progressive myoclonus epilepsies: specific causes and diagnosis. N Engl J Med (1986) 1.37
Creutzfeldt-Jakob disease presenting as isolated aphasia. Neurology (1989) 1.36
Physical separation of hemopoietic stem cells differing in their capacity for self-renewal. J Exp Med (1969) 1.36
Direct-to-consumer genetic testing: good, bad or benign? Clin Genet (2009) 1.34
Giant axonal neuropathy. A clinically and morphologically distinct neurological disease. Arch Neurol (1974) 1.34
Characterization of translational frame exception patients in Duchenne/Becker muscular dystrophy. Hum Mol Genet (1993) 1.33
Pregnancy and cystic fibrosis. Obstet Gynecol (1991) 1.33
A new concept of childhood nemaline myopathy. Arch Neurol (1971) 1.30
Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin. Am J Hum Genet (1991) 1.30
The ultrastructural characteristics of the abnormal cytosomes in Batten-Kufs' disease. Brain (1977) 1.29
Localization of the mdx mutation within the mouse dystrophin gene. EMBO J (1988) 1.29